GLPwatch
Altimmune
ALT · GLP-1 products, pipeline, and financials
Approved GLP-1 products (0)
No FDA-approved GLP-1 products from this manufacturer in our data.
Molecules (1)
Revenue (SEC) SEC EDGAR ↗
| Concept | Period end | Value | Form |
|---|---|---|---|
| Revenue | 2021-12-31 | $4.4M | 10-K |
| Revenue | 2020-12-31 | $8.2M | 10-K |
| Revenue | 2019-12-31 | $5.8M | 10-K |
| Revenue | 2018-12-31 | $10.3M | 10-K |
| Revenue | 2017-12-31 | $10.7M | 10-K |